Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases

NCT04582968 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Brain Metastases
HER2-positive Breast Cancer

Interventions

OTHER: Pyrotinib Plus Capecitabine combined with brain radiotherapy

Sponsor

Fudan University